Literature DB >> 32748621

Robot-assisted laparoscopic pyeloplasty in children: a systematic review.

Lorenzo Masieri1,2, Simone Sforza3,4, Antonio A Grosso4, Francesca Valastro4, Riccardo Tellini4, Chiara Cini3, Luca Landi3, Maria Taverna3, Antonio Elia3, Alberto Mantovani3, Andrea Minervini4, Marco Carini4.   

Abstract

INTRODUCTION: Open pyeloplasty has been the first-line treatment for uretero-pelvic junction obstruction for decades. In the last years, minimally-invasive surgery (MIS) has gained popularity in the pediatrics field. Furthermore, recently, a great extension of Robot-assisted laparoscopic pyeloplasty (RALP) has been seen in younger and lighter-weight children as well as in redo cases. Herein we provided a comprehensive review of primary and redo RALP performed in children, particularly focusing on the different distribution of outcomes among the ages. EVIDENCE ACQUISITION: A systematic review of the literature was performed according to PRISMA recommendations and was conducted on surgical indication and technique, intraoperative nuances, peri- and postoperative outcomes of primary and redo RALP. EVIDENCE SYNTHESIS: Overall, 33 studies with 1448 patients were included for primary RALP and 7 studies with 101 patients for redo cases between 2000 and 2019. In particular, 4 studies aimed to compare RALP in different cohorts of children grouped on ages or weight and 4 studies evaluated technical feasibility and safety of RALP over laparoscopic and open approach in very young populations. Success rate for primary RALP was found >90% in all studies but one, with low complication rate and preoperative indication. In redo series, 96% of patients revealed a decreased hydronephrosis on postoperative imaging.
CONCLUSIONS: RALP offers excellent outcomes in the pediatric population. However, there is still a strong need for higher quality evidence in the form of prospective observational studies and clinical trials. The rising of new robotic systems, such as single-port platform, might further enhance the applications of RALP in children.

Entities:  

Mesh:

Year:  2020        PMID: 32748621     DOI: 10.23736/S0393-2249.20.03854-0

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  5 in total

1.  Pediatric robotic surgery: issues in management-expert consensus from the Italian Society of Pediatric and Neonatal Anesthesia and Intensive Care (SARNePI) and the Italian Society of Pediatric Surgery (SICP).

Authors:  Simonetta Tesoro; Piergiorgio Gamba; Mirko Bertozzi; Rachele Borgogni; Fabio Caramelli; Giovanni Cobellis; Giuseppe Cortese; Ciro Esposito; Tommaso Gargano; Rossella Garra; Giulia Mantovani; Laura Marchesini; Simonetta Mencherini; Mario Messina; Gerald Rogan Neba; Gloria Pelizzo; Simone Pizzi; Giovanna Riccipetitoni; Alessandro Simonini; Costanza Tognon; Mario Lima
Journal:  Surg Endosc       Date:  2022-09-19       Impact factor: 3.453

Review 2.  Robotically Assisted Surgery in Children-A Perspective.

Authors:  Thomas Franz Krebs; Isabel Schnorr; Pascal Heye; Franz-Martin Häcker
Journal:  Children (Basel)       Date:  2022-06-06

3.  Development and Validation of a Scoring System for Assessment of Clinical Failure after Pediatric Robot-Assisted Laparoscopic Extravesical Ureteral Reimplantation: A Multi-Center Study.

Authors:  Chester J Koh; Kun Suk Kim; Jonathan A Gerber; Vinaya Bhatia; Huirong Zhu; Minki Baek; Sang Hoon Song
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

4.  Comparative study of different surgical approaches for treatment of UPJ obstruction according to the degree/severity of hydronephrosis factor.

Authors:  Peng Zhao; Cao Wang; Kaiyi Mao; Zhen Luo; Yingbo Li; Guangxu Zhou; Hongyang Tan; Hong Liu; Yucheng Mao; Hong Ma; Xianhui Shang; Bin Liu
Journal:  Front Pediatr       Date:  2022-08-04       Impact factor: 3.569

5.  Are there disparities in access to robot-assisted laparoscopic surgery among pediatric urology patients? US institutional experience.

Authors:  Amrita Mohanty; Alyssa M Lombardo; Clark Judge; Mohan S Gundeti
Journal:  Int J Urol       Date:  2022-03-26       Impact factor: 2.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.